Sample text. Sample text.
Recent post
-
1
Abrax Japan Announces Innovative Approach to Stimulate Weight Loss and Seek FDA Approval for Lipid Disorders
-
2
Abrax Japan Announces License Agreement with the University of Pennsylvania
-
3
Abrax Japan announces $3 million Seed 4 financing to support clinical development of ABX-919 for atopic dermatitis
-
4
Abrax Japan Appoints Dr. William Chin and Dr. Zoltan Arany to its Scientific Advisory Board
-
5
Abrax Japan Announces Completion of IND-Enabling Safety Studies to Advance Lead Program towards Clinical Trials
Popular Post List
-
1
Abrax Japan Announces Innovative Approach to Stimulate Weight Loss and Seek FDA Approval for Lipid Disorders
-
2
Abrax Japan Announces License Agreement with the University of Pennsylvania
-
3
Abrax Japan announces $3 million Seed 4 financing to support clinical development of ABX-919 for atopic dermatitis
-
4
Abrax Japan Appoints Dr. William Chin and Dr. Zoltan Arany to its Scientific Advisory Board
-
5
Abrax Japan Announces Completion of IND-Enabling Safety Studies to Advance Lead Program towards Clinical Trials
Comment